BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Zometa 4mg inf vials 0606020V0BBAAAA	Zometa	Zoledronic acid	Endocrine System	No data available
Zometa 4mg/100ml solution for infusion bottles 0606020V0BBACAD	Zometa	Zoledronic acid	Endocrine System	No data available
Zometa 4mg/5ml solution for infusion vials 0606020V0BBABAB	Zometa	Zoledronic acid	Endocrine System	No data available
Zonisamide 200mg capsules 0408010ADAAAIAI	Zonisamide	Zonisamide	Central Nervous System	No data available
Zopiclone 1.88mg/5ml oral suspension 0401010Z0AAAGAG	Zopiclone	Zopiclone	Central Nervous System	No data available
Zopiclone 5mg/5ml oral suspension 0401010Z0AAABAB	Zopiclone	Zopiclone	Central Nervous System	No data available
Zorac 0.1% gel 1305020T0BBABAB	Zorac	Tazarotene	Skin	No data available
Zorflex LA dressing 10.5cm x 10.5cm square 20031700313	Zorflex LA dressing 10.5cm x 10.5cm square	Wound Management & Other Dressings	Dressings	No data available
Zortress 250microgram tablets 0801050AXBEAAAD	Zortress	Everolimus	Malignant Disease and Immunosuppression	No data available
Zortress 750microgram tablets 0801050AXBEABAE	Zortress	Everolimus	Malignant Disease and Immunosuppression	No data available
Zotepine 100mg tablets 0402010ACAAACAC	Zotepine	Zotepine	Central Nervous System	No data available
Zotepine 25mg tablets 0402010ACAAAAAA	Zotepine	Zotepine	Central Nervous System	No data available
Zotepine 50mg tablets 0402010ACAAABAB	Zotepine	Zotepine	Central Nervous System	No data available
Zoton 15mg gastro-resistant capsules 0103050L0BBABAB	Zoton	Lansoprazole	Gastro-Intestinal System	No data available
Zoton 30mg gastro-resistant capsules 0103050L0BBAAAA	Zoton	Lansoprazole	Gastro-Intestinal System	No data available
Zoton 30mg gastro-resistant granules sachets 0103050L0BBACAD	Zoton	Lansoprazole	Gastro-Intestinal System	No data available
Zovirax 400mg dispersible tablets 0503021C0BBAHAH	Zovirax (Systemic)	Aciclovir	Infections	No data available
Zovirax I.V. 250mg powder for solution for infusion vials 0503021B0BBAAAA	Zovirax (Parenteral)	Aciclovir sodium	Infections	No data available
Zovirax I.V. 500mg powder for solution for infusion vials 0503021B0BBABAB	Zovirax (Parenteral)	Aciclovir sodium	Infections	No data available
Zubes Honey & Lemon lozenges 120303000BBBWA0	Proprietary compound preparation BNF 1203030	Other lozenge and spray preparations	Ear, Nose and Oropharynx	No data available
Zubes Original lozenges 120303000BBBQAH	Proprietary compound preparation BNF 1203030	Other lozenge and spray preparations	Ear, Nose and Oropharynx	No data available
Zubsolv 11.4mg/2.9mg sublingual tablets 0410030B0BCADAJ	Zubsolv	Buprenorph hydrochloride/naloxone hydrochloride	Central Nervous System	No data available
Zubsolv 2.9mg/0.71mg sublingual tablets 0410030B0BCABAH	Zubsolv	Buprenorph hydrochloride/naloxone hydrochloride	Central Nervous System	No data available
Zubsolv 5.7mg/1.4mg sublingual tablets 0410030B0BCACAI	Zubsolv	Buprenorph hydrochloride/naloxone hydrochloride	Central Nervous System	No data available
Zubsolv 8.6mg/2.1mg sublingual tablets 0410030B0BCABAF	Zubsolv	Buprenorph hydrochloride/naloxone hydrochloride	Central Nervous System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.